Woodford Investment Management
VC Fund
Oxford, United Kingdom
Woodford Investment Management is a privately owned investment firm manages equity mutual funds. At Woodford, they don’t want to be just another fund management company. They want to create something different and better for their investors and they feel strongly that existing and potential clients are entitled to understand what they are doingwith their money.As investors, they are active, engaged, long-term, disciplined, diligent and focused. That’s a lot of things to say about their selves but each word is important in helping you to understand how they manage money – they will explain in more detail as they move along.Their investment approach and process are focused on value discovery, not price discovery. They believe that financial markets are inherently inefficient and that, through disciplined and diligent analysis, they can identify investment opportunities where market prices do not reflect long-term fundamental value. By exploiting this pervasive market characteristic, they believe they can create real long-term value for their investors.
- Total investments:
- 63
- Last investment:
- Lead investor:
- 46%
- Fund size:
- $1.2B
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Woodford Investment Management invests in
Stages Woodford Investment Management invests in
Countries Woodford Investment Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $5.2M–$95M
- Series B
- $12M–$57M
- Venture - Series Unknown
- $6.5M–$115M
Investment Focus
Industry
- Biotechnology 23 (37%)
- Health Care 17 (27%)
- Medical 12 (19%)
- Therapeutics 9 (14%)
- Biopharma 7 (11%)
Stage
- Series B 12 (19%)
- Series A 11 (17%)
- Venture - Series Unknown 9 (14%)
- Series C 8 (13%)
- Private Equity 6 (10%)
Country
- United Kingdom 29 (46%)
- United States 10 (16%)
- Ireland 1 (2%)
- Australia 1 (2%)
- Switzerland 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Craig Newman
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Revolut is a financial services company that specializes in mobile banking, card payments, money remittance, and foreign exchange. It includes a pre-paid debit card, currency exchange, and peer-to-peer payments. It is on a mission to build a fair and frictionless platform to use and manage money around the world. | $13.7M / Venture - Series Unknown / Aug 12, 2021 | ||
| Atom Bank is a mobile banking application that offers a range of personal and business banking products. Users can log in using face and voice recognition and receive support from a 24/7 customer service team. The application, available on iPad and iPhone devices, was launched in March 2014 and its operations are based in Durham, the UnitedKingdom. | $65.5M / Jul 22, 2019 | ||
| Lithera is developing products for aesthetic medicine to address both medical and lifestyle indications. Its lead product is an injectable treatment to achieve local, selective fat tissue reduction (pharmaceutical lipoplasty). Using FDA registered drugs proven safe and effective in other indications, its product targets and stimulates natural fatmetabolism and achieves non-ablative, non-surgical fat tissue reduction in specific locations. | $50M / Post-IPO Equity / Jun 10, 2019 | ||
| Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients.Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collectedthrough a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated. | $52.6M / Series B / Mar 28, 2019 | ||
| Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagramThey will lead the way through this challenge, using their expertise and experience to unleash the potential ofgenomics and set the standards by which organisations and patients can benefit from genomic data. | $9.1M / Series B / Dec 09, 2018 | ||
| Ultraleap is the world leader in mid-air haptics and 3D hand tracking. The company's breakthrough haptic technology (previously Ultrahaptics) uses ultrasound to create rich, three-dimensional shapes and textures that can be felt, but not seen. | $44.6M / Series C / Dec 02, 2018 | ||
| Spin Transfer Technologies, Inc. was established by Allied Minds and New York University to develop and commercialize its orthogonal spin transfer magnetoresistive random access memory technology, OST-MRAM. The technology, discovered by Professor Andrew Kent, has enormous implications for the development of spin transfer MRAM devices, includingfaster switching times, lower power operation and scalability to smaller dimensions. | $52M / Series B / Nov 12, 2018 | ||
| LIGNIA is the company is helping to tackle issues around the limited supplies of legal and sustainable hardwoods | $9.7M / Venture - Series Unknown / Sep 07, 2018 | ||
| Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagramThey will lead the way through this challenge, using their expertise and experience to unleash the potential ofgenomics and set the standards by which organisations and patients can benefit from genomic data. | $32.5M / Series B / Aug 30, 2018 | ||
| Metaboards is a pioneer in metamaterials – the science of creating materials in a certain shapes, sizes or orientations to give it unique properties that would not be found in nature – in this case the ability to wirelessly charge devices. That enables many electronic devices to be powered across large surfaces without the need for alignment ormultiple power inputs. Our mission is to test the boundaries of what is possible with metamaterials to create market leading products using cutting edge technologies. | $5M / Series A / Jun 12, 2018 | ||
| See all 63 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Woodford Investment Management invest in?
Woodford Investment Management invests primarily in Biotechnology, Health Care and Medical startups, most often at Series B and Series A stage. Most of the 63 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Woodford Investment Management's check size?
Woodford Investment Management typically joins rounds of $5.2M–$95M at Series A, $12M–$57M at Series B and $6.5M–$115M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Woodford Investment Management participates in.
How do I contact Woodford Investment Management?
Public channels for Woodford Investment Management include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Woodford Investment Management?
The team at Woodford Investment Management includes Craig Newman (Chief Executive Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
